Presentation is loading. Please wait.

Presentation is loading. Please wait.

Risk of recurrence of Barrett’s esophagus after successful endoscopic therapy  Rajesh Krishnamoorthi, MD, Siddharth Singh, MD, Karthik Ragunathan, MD,

Published byHester Martin Modified over 5 years ago

Similar presentations

Presentation on theme: "Risk of recurrence of Barrett’s esophagus after successful endoscopic therapy  Rajesh Krishnamoorthi, MD, Siddharth Singh, MD, Karthik Ragunathan, MD,"— Presentation transcript:

1 Risk of recurrence of Barrett’s esophagus after successful endoscopic therapy 
Rajesh Krishnamoorthi, MD, Siddharth Singh, MD, Karthik Ragunathan, MD, David A. Katzka, MD, Kenneth K. Wang, MD, Prasad G. Iyer, MD, MSc, FASGE  Gastrointestinal Endoscopy  Volume 83, Issue 6, Pages e3 (June 2016) DOI: /j.gie Copyright © 2016 American Society for Gastrointestinal Endoscopy Terms and Conditions

2 Figure 1 Flow sheet summarizing study identification and selection.
Gastrointestinal Endoscopy  , e3DOI: ( /j.gie ) Copyright © 2016 American Society for Gastrointestinal Endoscopy Terms and Conditions

3 Figure 2 A, Incidence of recurrent IM after achieving CRIM using any endoscopic modality in patients with BE. B, Incidence of recurrent DBE after achieving CRIM using any endoscopic modality in patients with BE. C, Incidence of recurrent HGD/EAC after achieving CRIM using any endoscopic modality in patients with BE. IM, intestinal metaplasia; CRIM, complete remission of intestinal metaplasia; BE, Barrett's esophagus; HGD/EAC, high-grade dysplasia/ esophageal adenocarcinoma. Gastrointestinal Endoscopy  , e3DOI: ( /j.gie ) Copyright © 2016 American Society for Gastrointestinal Endoscopy Terms and Conditions

4 Figure 2 A, Incidence of recurrent IM after achieving CRIM using any endoscopic modality in patients with BE. B, Incidence of recurrent DBE after achieving CRIM using any endoscopic modality in patients with BE. C, Incidence of recurrent HGD/EAC after achieving CRIM using any endoscopic modality in patients with BE. IM, intestinal metaplasia; CRIM, complete remission of intestinal metaplasia; BE, Barrett's esophagus; HGD/EAC, high-grade dysplasia/ esophageal adenocarcinoma. Gastrointestinal Endoscopy  , e3DOI: ( /j.gie ) Copyright © 2016 American Society for Gastrointestinal Endoscopy Terms and Conditions

5 Figure 2 A, Incidence of recurrent IM after achieving CRIM using any endoscopic modality in patients with BE. B, Incidence of recurrent DBE after achieving CRIM using any endoscopic modality in patients with BE. C, Incidence of recurrent HGD/EAC after achieving CRIM using any endoscopic modality in patients with BE. IM, intestinal metaplasia; CRIM, complete remission of intestinal metaplasia; BE, Barrett's esophagus; HGD/EAC, high-grade dysplasia/ esophageal adenocarcinoma. Gastrointestinal Endoscopy  , e3DOI: ( /j.gie ) Copyright © 2016 American Society for Gastrointestinal Endoscopy Terms and Conditions

6 Figure 3 A, Incidence of recurrent IM after achieving CRIM using RFA in patients with BE. B, Incidence of recurrent DBE after achieving CRIM using RFA in patients with BE. C, Incidence of recurrent HGD/EAC after achieving CRIM using RFA in patients with BE. IM, intestinal metaplasia; CRIM, complete remission of intestinal metaplasia; RFA, radiofrequency ablation; Barrett's esophagus; DBE, dysplastic Barrett's esophagus; HGD/EAC, high-grade dysplasia/ esophageal adenocarcinoma. Gastrointestinal Endoscopy  , e3DOI: ( /j.gie ) Copyright © 2016 American Society for Gastrointestinal Endoscopy Terms and Conditions

7 Figure 3 A, Incidence of recurrent IM after achieving CRIM using RFA in patients with BE. B, Incidence of recurrent DBE after achieving CRIM using RFA in patients with BE. C, Incidence of recurrent HGD/EAC after achieving CRIM using RFA in patients with BE. IM, intestinal metaplasia; CRIM, complete remission of intestinal metaplasia; RFA, radiofrequency ablation; Barrett's esophagus; DBE, dysplastic Barrett's esophagus; HGD/EAC, high-grade dysplasia/ esophageal adenocarcinoma. Gastrointestinal Endoscopy  , e3DOI: ( /j.gie ) Copyright © 2016 American Society for Gastrointestinal Endoscopy Terms and Conditions

8 Figure 4 Funnel plot assessing publication bias in primary analysis.
Gastrointestinal Endoscopy  , e3DOI: ( /j.gie ) Copyright © 2016 American Society for Gastrointestinal Endoscopy Terms and Conditions

9 Gastrointestinal Endoscopy 2016 83, 1090-1106. e3DOI: (10. 1016/j. gie
Copyright © 2016 American Society for Gastrointestinal Endoscopy Terms and Conditions

10 Gastrointestinal Endoscopy 2016 83, 1090-1106. e3DOI: (10. 1016/j. gie
Copyright © 2016 American Society for Gastrointestinal Endoscopy Terms and Conditions

Download ppt "Risk of recurrence of Barrett’s esophagus after successful endoscopic therapy  Rajesh Krishnamoorthi, MD, Siddharth Singh, MD, Karthik Ragunathan, MD,"

Similar presentations

Endoscopic Treatment of Barrett’s Esophagus and Early Esophageal Cancer CTOP Retreat 2014 Dartmouth-Hitchcock Medical Center.

Endoscopic Treatment of Barrett’s Esophagus and Early Esophageal Cancer CTOP Retreat 2014 Dartmouth-Hitchcock Medical Center.
Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer 

Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer 
The cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low- grade dysplasia: results from a randomized controlled trial (SURF trial) 

The cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low- grade dysplasia: results from a randomized controlled trial (SURF trial) 
Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study  Andreas Stang, MD, MPH, Thomas.

Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study  Andreas Stang, MD, MPH, Thomas.
Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis  Marjolein Sikkema, Pieter.

Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis  Marjolein Sikkema, Pieter.
Esophageal Adenocarcinoma

Esophageal Adenocarcinoma
Fig. 1 Flow diagram of patient selection and study design.

Fig. 1 Flow diagram of patient selection and study design.
Julian A. Abrams, MD, MS, Sri Komanduri, MD, Nicholas J

Julian A. Abrams, MD, MS, Sri Komanduri, MD, Nicholas J
Long-term follow-up results of stepwise radical endoscopic resection for Barrett’s esophagus with early neoplasia  Kamar Belghazi, MD, Frederike G.I.

Long-term follow-up results of stepwise radical endoscopic resection for Barrett’s esophagus with early neoplasia  Kamar Belghazi, MD, Frederike G.I.
Barrett's esophagus: diagnosis and management

Barrett's esophagus: diagnosis and management
Sa1536 Efficacy and Safety of Extensive Endomucosal Resection for Complete Barrett's Eradication in Early Barrett's Neoplasia: A Meta-Analysis  Rajesh.

Sa1536 Efficacy and Safety of Extensive Endomucosal Resection for Complete Barrett's Eradication in Early Barrett's Neoplasia: A Meta-Analysis  Rajesh.
Kulwinder S. Dua, MD, Joseph Merrill, MD  Gastrointestinal Endoscopy 

Kulwinder S. Dua, MD, Joseph Merrill, MD  Gastrointestinal Endoscopy 
Endoscopic eradication therapy for patients with Barrett’s esophagus–associated dysplasia and intramucosal cancer  Sachin Wani, MD, Bashar Qumseya, MD,

Endoscopic eradication therapy for patients with Barrett’s esophagus–associated dysplasia and intramucosal cancer  Sachin Wani, MD, Bashar Qumseya, MD,
Volume 149, Issue 3, Pages e3 (September 2015)

Volume 149, Issue 3, Pages e3 (September 2015)
Public health impact of colonoscopy use on colorectal cancer mortality in Germany and the United States  Chen Chen, MSPH, Christian Stock, PhD, Michael.

Public health impact of colonoscopy use on colorectal cancer mortality in Germany and the United States  Chen Chen, MSPH, Christian Stock, PhD, Michael.
Gastrointestinal Endoscopy

Gastrointestinal Endoscopy
Comparison of EUS with MRCP in idiopathic acute pancreatitis: a systematic review and meta-analysis  Jianhua Wan, MD, Yaobin Ouyang, MD, Chen Yu, MD,

Comparison of EUS with MRCP in idiopathic acute pancreatitis: a systematic review and meta-analysis  Jianhua Wan, MD, Yaobin Ouyang, MD, Chen Yu, MD,
Terry L. Jue, MD  Gastrointestinal Endoscopy 

Terry L. Jue, MD  Gastrointestinal Endoscopy 
Single-balloon enteroscopy-assisted ERCP in patients with surgically altered GI anatomy: getting there  Barham Abu Dayyeh, MD, MPH  Gastrointestinal Endoscopy 

Single-balloon enteroscopy-assisted ERCP in patients with surgically altered GI anatomy: getting there  Barham Abu Dayyeh, MD, MPH  Gastrointestinal Endoscopy 
Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma  Jörg Zehetner, MD, Steven R. DeMeester,

Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma  Jörg Zehetner, MD, Steven R. DeMeester,

Similar presentations

Ads by Google